GWLL · Goldenwell Biotech, Inc. · Executive Compensation
$0.65
+0.00 (+0.00%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon, among other things, its ability to generate revenues and its ability to obtain capital from third parties. No assurance can be given that the Company will be successful in these efforts.”View the 10-Q filed Aug 14, 2026
Market Cap
$64.35M
Shares
99.00M
Volume · Oct 20
100
Avg daily vol (7 sessions)
648
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ming Zhou | director | Appointed | 2026-10-09 |
Leadership
- Ming Zhou Board Member